AtorTint M Tablet 10 mg (Atorvastatin Calcium Trihydrate)

Adult dose

For hyperlipidemia, the recommended initial dose is 10 mg once daily; for patients needing greater LDL-cholesterol reduction, treatment may begin with 20 mg or 40 mg once daily. The dosage range is 10-80 mg once daily, and it should be individualized according to treatment goals and patient characteristics, adjusting the dose after 2-4 weeks. For patients with homozygous familial hypercholesterolemia, the dosage is 10-80 mg once daily.

Child dose

For pediatric patients (10-17 years old) with heterozygous familial hypercholesterolemia, the recommended initial dose is 10 mg once daily, and the recommended maximum dose is 20 mg once daily. The dosage should be adjusted appropriately according to the treatment goals.

This medication may cause muscle problems; therefore, if muscle pain or weakness worsens or if creatine kinase levels rise significantly, it should be discontinued immediately. Patients at high risk for severe myopathy or rhabdomyolysis should temporarily stop or discontinue the use of this medication. This drug should not be used in certain patients, for example, those with allergies to this medicine or its components, active liver disease, muscle disease, pregnant or breastfeeding women, children under 10 years of age, or those taking certain antiviral medications. Care should be taken when this medication is used in alcoholics, individuals with a history of liver disease, patients with impaired kidney function, those with hypothyroidism, individuals with a history of muscle disorders, and the elderly. While this medication is generally well tolerated, various side effects such as fatigue, headache, dyspepsia, myalgia, liver function abnormality, skin rash can occur; thus, any unusual symptoms should be discussed with a physician. Specifically, if muscle pain or weakness is severe or persistent, medical personnel should be informed, and blood tests may be necessary to check for muscle damage. This medication can affect liver and kidney functions, so regular liver function tests and kidney function tests should be conducted, and if symptoms of hepatitis appear (nausea, vomiting, fatigue, etc.), use should be discontinued immediately. Women of childbearing potential must use appropriate contraceptive methods while taking this medication and should not use it during pregnancy. This drug can interact with many other medications; therefore, if you are taking other medicines, you must inform your healthcare provider, especially when taking certain antibiotics, antiviral medications, antifungals, antihypertensives, hypoglycemics, or oral contraceptives. In cases of overdose, there is no specific antidote, so treatment should be symptom-based, and blood tests should monitor the status of the liver and muscles. This medication should be stored out of reach of children and kept in its original container for safety. Elderly patients or those with impaired kidney function are at higher risk for muscle-related side effects with this drug and should be monitored more closely.

Serious side effects

• Hives
• angioedema
• anaphylaxis
• erythema multiforme
• Stevens-Johnson syndrome
• toxic epidermal necrolysis
• cholestatic jaundice
• jaundice
• rhabdomyolysis
• shortness of breath

Mild side effects

• Weakness
• malaise
• chest pain
• peripheral edema
• fatigue
• fever
• nasopharyngitis
• hyperglycemia
• hypoglycemia
• weight gain

This medication must be stored in a tightly closed container to prevent exposure to air or moisture. It is also safe to store this medication at room temperature, between 1 to 30 degrees Celsius.

Appearance

White, round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle